CTN - 0051: Extended-Release Naltrexone vs. Bupren... (ID 824589) - BioProject

Display Settings:

Format

Summary
BioProject ID list
Accessions List

Send to:

Choose Destination

File
Clipboard
Collections
My Bibliography

Accession: PRJNA824589 ID: 824589

CTN - 0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) (human)

See Genome Information for Homo sapiens

Navigate Up

This project is a component of the CTN - 0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)

Navigate Across

95322 additional projects are related by organism.

The overarching goal of CTN-0051 is to foster adoption of new relapse-prevention pharmacotherapies in community-based treatment programs (CTPs) where these could have a substantial public health impact. More...

Accession	PRJNA824589; dbGaP: phs002876
Data Type	Phenotype or Genotype
Scope	Multiisolate
Organism	Homo sapiens[Taxonomy ID: 9606] Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
Submission	Registration date: 7-Apr-2022 NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Relevance	Medical

Project Data:

Resource Name	Number of Links
Genotype and Phenotype (dbGaP)	1

BioProject

Result Filters

Display Settings:

Send to:

CTN - 0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) (human)

Supplemental Content

Related information

Recent activity